David Bellinger, Mizuho, joins 'Fast Money' to talk the upcoming slate of retail earnings.

image for news Looking at tariff cost push forward to consumers in Walmart earnings, says Mizuho's David Bellinger

Final Trade: UNH, VB, QQQ, LYFT — Neutral

LYFT  QQQ  UNH  VB   CNBC Television — August 15, 2025

The final trades of the day with the Fast Money traders.

image for news Final Trade: UNH, VB, QQQ, LYFT

Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.

image for news Wall Street pulls back from gold market after Swiss tariff drama, Main Street majority still expects gains during Fed-heavy week

SECAUCUS, N.J. , Aug. 15, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance and the latest market developments and trends during the Baird 2025 Global Healthcare Conference in New York City on Wednesday, September 10, 2025, at 10:50 a.m.

image for news Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference

Bridgewater Associates exited its investments in five Chinese stocks in the second quarter, including e-commerce giant Alibaba.

image for news World's Largest Hedge Fund Sells Alibaba, Baidu, Nio, and More Chinese Stocks

Credicorp Ltd. (BAP) Q2 2025 Earnings Call Transcript — Neutral

BAP   Seeking Alpha — August 15, 2025

Credicorp Ltd. (NYSE:BAP ) Q2 2025 Earnings Conference Call August 15, 2025 10:30 AM ET Company Participants Alejandro Perez-Reyes Zarak - Chief Financial Officer Cesar Rios Briceno - Chief Risk Officer Francesca Raffo Paine - Chief Innovation Officer Gianfranco Piero Dario Ferrari de Las Casas - Chief Executive Officer Milagros Cigüeñas - Head of Investor Relations Conference Call Participants Alonso Acuna Aramburú - Banco BTG Pactual S.A.

image for news Credicorp Ltd. (BAP) Q2 2025 Earnings Call Transcript

NEW YORK, Aug. 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of iRobot Corporation (NASDAQ: IRBT) between January 29, 2024 and March 11, 2025, both dates inclusive (the “Class Period”), of the important September 5, 2025 lead plaintiff deadline.

image for news IRBT DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages iRobot Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - IRBT

UnitedHealth: Berkshire Bets, A Strategic Signal Investors Can't Ignore — Positive

BRK-A  BRK-B  UNH   Seeking Alpha — August 15, 2025

Berkshire Hathaway's UnitedHealth Group Incorporated share purchase signals confidence in a sector where it has deep operational expertise. UnitedHealth remains systemically vital; no one, or possibly collection of competitors can absorb its market share or infrastructure. UNH stock trades ~56% below all-time high, offering ~127% upside potential if the shares return to those levels plus a growing dividend yield.

image for news UnitedHealth: Berkshire Bets, A Strategic Signal Investors Can't Ignore

NEW YORK, Aug. 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common units of XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP (NYSE: XIFR, NEP) between September 27, 2023 and January 27, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 8, 2025.

image for news ROSEN, LEADING TRIAL ATTORNEYS, Encourages XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP Investors to Secure Counsel Before Important Deadline in Securities Class Action – XIFR, NEP

NEW YORK, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Enigmatig Limited (NYSE American: EGG) (“Enigmatig” or the “Company”), a global business enabler empowering small and medium-sized enterprises (SMEs) to scale across borders, today rang the Closing Bell at the New York Stock Exchange (“NYSE”) to mark its recent listing and reaffirm its mission to power the global ambitions of bold, forward-thinking businesses.

image for news Enigmatig Celebrates NYSE American Listing with Bell Ringing Ceremony, Signaling Next Phase of Global Growth

Novo Nordisk said on Friday the U.S. Food and Drug Administration had granted accelerated approval for its weight-loss drug Wegovy to treat a serious liver condition known as metabolic dysfunction-associated steatohepatitis.

image for news Novo Nordisk's Wegovy gets accelerated US FDA approval for liver disease MASH

3 Restaurant Stocks That Will Outperform in Q3 and Q4 — Positive

CMG  SBUX  WING   MarketBeat — August 15, 2025

There are headwinds for restaurant stocks, and they may increase as the year progresses, but companies like Chipotle Mexican Grill NYSE: CMG, Wingstop NASDAQ: WING, and Starbucks NASDAQ: SBUX are on track to outperform and increase their stock prices. Each has a unique catalyst to support shareholder value and is in a position to outperform its peers and the broader market.

image for news 3 Restaurant Stocks That Will Outperform in Q3 and Q4

Why Cava stock plummeted 18% this week — Negative

CAVA   CNBC Television — August 15, 2025

Cava stock just wrapped up one its worst weeks ever after missing on Q2 revenue estimates and lowering its full-year same-store sales growth target for the first time. Shares of the fast-casual chain have fallen nearly 40% this year, despite soaring 160% in 2024.

image for news Why Cava stock plummeted 18% this week

TAMPA, FL / ACCESS Newswire / August 15, 2025 / Generation Income Properties, Inc. (NASDAQ:GIPR) ("GIPR" or the "Company") today announced its three-month financial and operating results for the period ended June 30, 2025. Portfolio Approximately 60% of our portfolio's annualized rent as of June 30, 2025, was derived from tenants that have (or whose parent company has) an investment grade credit rating from a recognized credit rating agency of "BBB-" or better.

image for news Generation Income Properties Announces Q2 2025 Financial and Operating Results

Josh Hawley, Republican of Missouri, said he would look into whether the social media company's artificial intelligence technology endangers children.

image for news Senator Josh Hawley Begins Child Safety Inquiry Into Meta's A.I. Bot

Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates (Revised) — Negative

ZVRA   Zacks Investment Research — August 15, 2025

Zevra Therapeutics (ZVRA) came out with a quarterly earnings of $1.21 per share versus the Zacks Consensus Estimate of $2.19. This compares to a loss of $0.48 per share a year ago.

image for news Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates (Revised)

Nubank Stock Surges As Second Quarter Earnings Exceed Expectations — Positive

NU   Forbes — August 15, 2025

On Thursday night, Latin American digital bank Nubank announced revenue and profits that beat analysts' expectations. Its share price jumped 10% on Friday to above $13.00, pushing its market value to nearly $64 billion.

image for news Nubank Stock Surges As Second Quarter Earnings Exceed Expectations

FUKUOKA, Japan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or the “Company”), a Japanese labor consulting and health services company, today announced the closing of its initial public offering of 1,250,000 Japanese common shares at a public offering price of US$4.00 per share. The total gross proceeds from the offering, before deducting underwriting discounts and other offering expenses payable by rYojbaba, was US$5 million. rYojbaba's Japanese common shares began trading on the Nasdaq Capital Market on August 14, 2025, under the ticker symbol “RYOJ”.

image for news rYojbaba Co., Ltd. Announces Closing of $5 Million Initial Public Offering of Japanese Common Shares

Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH — Neutral

NVO   GlobeNewsWire — August 15, 2025

Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an additional indication for Wegovy® (semaglutide 2.4 mg) based on a supplemental New Drug Application (sNDA) for treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), in combination with a reduced calorie diet and increased physical activity.

image for news Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH

Magnitude of Tapestry pullback is surprising, says Bernstein's Aneesha Sherman — Negative

TPR   CNBC Television — August 15, 2025

Aneesha Sherman, Bernstein, joins 'Closing Bell Overtime' to talk upcoming retail earnings and the recent drop in Tapestry stock.

image for news Magnitude of Tapestry pullback is surprising, says Bernstein's Aneesha Sherman